{"DataElement":{"publicId":"2861356","version":"1","preferredName":"Systemic Therapy Indication","preferredDefinition":"The indicator that describes the indication for system therapy.","longName":"SYS_THERAP_IND","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2861354","version":"1","preferredName":"Systemic Therapy Indication","preferredDefinition":"(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"SYS_THERAP_IND","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2744148","version":"1","preferredName":"Systemic Therapy","preferredDefinition":"(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","longName":"C15698","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic Therapy","conceptCode":"C15698","definition":"Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B8D73DA-C8DE-4594-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-23","modifiedBy":"ONEDATA","dateModified":"2008-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2193066","version":"1","preferredName":"Indication","preferredDefinition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"C41184","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EAA83722-8121-511A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-08","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67AE3308-C87D-84F3-E040-BB89AD437839","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"NYCHM","dateModified":"2017-03-01","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2861304","version":"1","preferredName":"Systemic Therapy Indicator","preferredDefinition":"(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"SYS_THERAP_IND","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67AD9A2F-1249-E58B-E040-BB89AD437C2B","beginDate":"2009-04-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"ONEDATA","dateModified":"2009-04-16","deletedIndicator":"No"},{"value":"Induce Complete Remission","valueDescription":"Induction Complete Remission","ValueMeaning":{"publicId":"2861305","version":"1","preferredName":"Induction Complete Remission","longName":"2861305","preferredDefinition":"The act of bringing about something.: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67AD9A2F-1256-E58B-E040-BB89AD437C2B","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67AD9A2F-126F-E58B-E040-BB89AD437C2B","beginDate":"2009-04-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"ONEDATA","dateModified":"2009-04-16","deletedIndicator":"No"},{"value":"Bone Marrow Failure","valueDescription":"Bone Marrow Failure","ValueMeaning":{"publicId":"2718358","version":"1","preferredName":"Bone Marrow Failure","longName":"2718358","preferredDefinition":"The soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow","conceptCode":"C12431","definition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42D5D049-0367-6FD0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67AD9A2F-1279-E58B-E040-BB89AD437C2B","beginDate":"2009-04-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"ONEDATA","dateModified":"2009-04-16","deletedIndicator":"No"},{"value":"Progression to leukemia","valueDescription":"Disease Progression Acute Myeloid Leukemia","ValueMeaning":{"publicId":"4746340","version":"1","preferredName":"Disease Progression Acute Myeloid Leukemia","longName":"4746340","preferredDefinition":"The worsening of a disease over time.: A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise categorized. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acute Myeloid Leukemia","conceptCode":"C3171","definition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11814A91-B4C0-F981-E050-BB89AD4341B2","latestVersionIndicator":"Yes","beginDate":"2015-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11814A91-B4D9-F981-E050-BB89AD4341B2","beginDate":"2009-04-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-17","modifiedBy":"ONEDATA","dateModified":"2015-03-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2861303","version":"1","preferredName":"Systemic Therapy Indicator","preferredDefinition":"(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C15698:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic Therapy","conceptCode":"C15698","definition":"Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67AD9A2F-1210-E58B-E040-BB89AD437C2B","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"ONEDATA","dateModified":"2009-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67AD9A2F-1221-E58B-E040-BB89AD437C2B","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"NYCHM","dateModified":"2017-03-01","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964931","version":"1","longName":"2014r1: MDS Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"2842912","version":"1","longName":"Therapy","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2842916","version":"1","longName":"Systemic","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"mds_base_tx_indication","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedProcedure:reasonCode","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Indication for therapy:","type":"Preferred Question Text","description":"Indication for therapy:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2861356","type":"BRIDG Mapping Path","description":"PerformedProcedure.reasonCode","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"67AE3308-C890-84F3-E040-BB89AD437839","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":"2014-05-21","createdBy":"ZHANGW","dateCreated":"2009-04-16","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}